On December 17, 2019, The Food and Drug Administration (FDA) proposed guidance for the importation of medications from Canada. The goal of this proposal is to allow patients access to FDA approved medications from abroad at a lower cost. The guidance would allow states, wholesalers, and pharmacies to come up with proposals for safe importation [...]

  The U.S. Department of Health and Human Services recently released two sets of regulations that would make health care costs publicly available.  These regulations could significantly shake up the health care space making it easier for employers to design health benefits to steer employees toward hospitals with high value services. The first regulation (found HERE) [...]

The U.S. Food and Drug Administration (FDA) is expected to decide on two new peanut allergy therapies in the next 6 months. These emerging medications are expected shift how patients with this condition are treated. The American College of Allergy, Asthma, & Immunology estimates approximately 2.2% of children and adolescents have a peanut allergy. Allergic [...]